Skip to main content

Find Clinical Trials

Home
Conditions
Hepatitis C

Clinical trial condition

Hepatitis C

Explore clinical trials studying Hepatitis C. Study availability and eligibility vary by location and protocol.

1,296 public trials 40 recruiting studies

Refine in advanced search Browse all conditions

Hepatitis C trial results

Completed

TMC435350-TiDP16-C106: A Phase I Trial to Compare the Bioavailability and Plasma Pharmacokinetics After a Single Oral Dose of TMC435350 of 2 Different Solid Formulations Relative to a Powder Blend Capsule

NCT00752648

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations: Not specified

View Trial Details

Completed

TMC435-TiDP16-C107: This Study Measures the (Possible) Influence of TMC435 on the Activity of a Selected Set of Drug-degrading Proteins by Measuring the Blood Levels of Drugs That Have Been Taken Together With TMC435 and That Are Known to be Specifically Degraded by These Drug-degrading Proteins.

NCT00866853

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations: Not specified

View Trial Details

Completed

A Study of MDX-1106 to Treat Patients With Hepatitis C Infection

NCT00703469

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Advanced Clinical Resesarch Institute Anaheim, California, United States

Quest Clinical Research San Francisco, California, United States

Springfield Clinic Infectious Diseases Springfield, Illinois, United States

John Hopkins University School of Medicine, Viral Hepatitis Center Baltimore, Maryland, United States

View Trial Details

Completed

A Study to Examine the Effects of Telaprevir on the Pharmacokinetics of Cyclosporine and Tacrolimus in Healthy Adults

NCT01038167

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Dallas, Texas, United States

View Trial Details

Completed

Antiviral Activity of AZD7295 in HCV Carriers

NCT00781976

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Prof Ed Gane Auckland, New Zealand

View Trial Details

Completed

Hepatitis C: Grading and Staging by MR

NCT00059397

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Thomas Jefferson University Hospital Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Fourteen Day Safety of Low-Dose Tamoxifen in Patients With Chronic Hepatitis C Who Have Failed Standard Medical Therapy

NCT00749138

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations: VA Hospital Oklahoma City, Oklahoma, United States

View Trial Details

Completed

Prophylaxis of Psychiatric Symptoms During Anti-HCV Treatment

NCT00133276

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Erasmus MC University Hospital Rotterdam, South Holland, Netherlands

AMC Amsterdam, Netherlands

Radboud University Hospital Nijmegen, Netherlands

View Trial Details

Completed

Clinical Pharmacology Study of AZD7295 in Healthy Subjects

NCT00906256

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations: Pharmaceutical Profiles Ltd Nottingham, United Kingdom

View Trial Details

Completed

Phase I Hepatitis C Vaccine Trial of Virosome-formulated Peptides

NCT00445419

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations: Vaccine and Immunotherapy Center, CHUV Lausanne, Switzerland

View Trial Details